Sign in

CIK 0001111485

  • Accelerated filer

RxSight, Inc.

Sign in to watch
Ticker
RXST
Exchange
Nasdaq
Industry
Ophthalmic Goods
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943268801
Phone
+1 949-521-7822
Business address
100 COLUMBIA STREET, SUITE 120, ALISO VIEJO, CA, 92656
Former names
CALHOUN VISION INC
  1. 4 Planned sale Chief Financial Officer sold 40,000 shares at an average $39.33 ($1,573,310)
  2. 4 Planned sale Director sold 12,000 shares at an average $40.12 ($481,469)
  3. 4 Planned sale President & CEO sold 40,000 shares at an average $39.70 ($1,588,186)
  4. 4 Planned sale Director sold 20,000 shares at an average $35.03 ($700,551)
  5. 4 Open-market sale Director sold 494,313 shares at an average $29.73 ($14,695,695)
  6. 4 Open-market sale Director sold 500,000 shares at an average $27.18 ($13,590,750)
  7. 4 Other disposition Director disposed of 81,450 shares (other)
  8. 4 Open-market sale Director sold 32,950 shares at an average $30.14 ($992,969)
  9. 4 Planned sale Director sold 4,292 shares at $28.06 ($120,451)
  10. 4 Open-market sale Director sold 16,208 shares at $29.25 ($474,129)
  11. 4 Other disposition Director disposed of 694,124 shares (other)
  12. 4 Other acquisition Director acquired 82,654 shares (other)
  13. 4 Open-market sale Director sold 33,135 shares at an average $29.62 ($981,570)
  14. 4 Other disposition Director disposed of 497,150 shares (other)
  15. 4 Option exercise Chief Operating Officer acquired 25,475 shares (option exercise)
  16. 4 Other disposition Director disposed of 267,300 shares (other)
  17. 4 Grant or award Director acquired 5,731 shares (grant or award)
  18. 4 Grant or award Director acquired 5,731 shares (grant or award)
  19. 4 Grant or award Director acquired 5,731 shares (grant or award)
  20. 4 Grant or award Director acquired 5,731 shares (grant or award)

Page 7 of 11 · 208 filings